Brief: Klaria: Positive Pre-Clinical Results With Cannabinoid CBD

Klaria Pharma Holding AB (publ)

23/05/2019 07:49

May 23 (Reuters) - Klaria Pharma Holding AB (publ)
 KLAR.ST :
    * KLARIA ANNOUNCES POSITIVE PRE-CLINICAL PROOF-OF-CONCEPT
STUDY
RESULTS WITH THE CANNABINOID CBD, SUPERIOR DATA ON BOTH TESTED
OUTCOME MEASURES DEMONSTRATED
    * RESULTS DEMONSTRATE THAT KLARIA'S TECHNOLOGY HAS POTENTIAL
TO
SIGNIFICANTLY IMPROVE DELIVERY OF CANNABIS-DERIVED COMPOUNDS
    * POC STUDY WAS POSITIVE ON BOTH KEY MEASURES

Source text for Eikon:  ID:nWkr38P2rq 
Further company coverage:  KLAR.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))